RM

Ravi Mavjibhai Kalathiya

Active Director Director DIN 09471589
DIN 09471589 First appointment Jan 2022 Primary industry Non-Profit Organizations
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2022
Shareholding value •••• Premium profile

About Ravi Mavjibhai Kalathiya

Data last updated:

Ravi Mavjibhai Kalathiya is a Director at Medivoice Pharma Private Limited (since 2022). The company operates in Non-Profit Organizations. Medivoice Pharma Private Limited reported revenue of ₹9.2 Lakh (FY 2023).

DIN 09471589
Primary Designation Director
Industry Non-Profit Organizations
First Appointment 18 Jan 2022
Oldest Company Age 4 yrs
Largest company Medivoice Pharma Private Limited · ₹9.2 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medivoice Pharma Private Limited U85300MH2022PTC375065
Director18 Jan 20222022₹9.2 Lakh (FY 2023)Active

Board colleagues of Ravi Mavjibhai Kalathiya

Directorship timeline

Open interactive timeline →
Medivoice Pharma Private Limited
Premium access

Shareholding and investment profile for Ravi Mavjibhai Kalathiya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravi Mavjibhai Kalathiya

Ravi Mavjibhai Kalathiya currently holds 1 directorship: Medivoice Pharma Private Limited (Director, since 18 Jan 2022, revenue ₹9.2 Lakh (FY 2023)).

Ravi Mavjibhai Kalathiya was first appointed on 18 Jan 2022 as Director at Medivoice Pharma Private Limited.

The current boards of Ravi Mavjibhai Kalathiya's companies include Mayur Chandubhai Lakhani (Medivoice Pharma Private Limited), Sahilkumar Ashokbhai Vaghasiya (Medivoice Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available